|
|
 | | | |
- close
- close
- close
- close
Vanda Pharmaceuticals (VNDA) |
QUOTE AND NEWS
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vanda+Pharmaceuticals%2C+Inc.+%28VNDA%29+Misses+Q1+Views/7412009.html for the full story.
PR Newswire
May 8
Comment
WASHINGTON, May 8, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced
PR Newswire
Apr 18
Comment
WASHINGTON, April 18, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will
Reuters
Apr 16
Comment
Vanda Pharmaceuticals Inc said
it acquired from Eli Lilly the worldwide development and
commercialization rights of a molecule for the treatment of
several indications, including...
StreetInsider.com
Apr 16
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharmaceuticals+%28VNDA%29+Gets+NK-1R+License+Agreement+with+Lilly+%28LLY%29/7344790.html for the full story.
Benzinga
Mar 13
Comment
Jefferies cuts its rating on Vanda Pharmaceuticals (NASDAQ: VNDA) to Hold from Buy on lower estimates for WW Fanapt. Price target is also lowered $4 to $4.50.
Jefferies says, "With TRxs flattening, additional brands (Zyprexa & Geodon) going...
Forbes
Jan 21
Comment
Last week I wrote about Vanda Pharmaceuticals (NASDAQ:VNDA) and TIAA-CREF. I wrote about how TIAA-CREF had a large position in Vanda Pharmaceuticals and how TIAA-CREF had placed a micro-cap stock into a large-cap portfolio. Normally I would...
Forbes
Jan 20
Comment
As a quant, I look at connections between the stock that a firm holds and the actual firm. I’m not looking for a conspiracy or anything beyond that. But, as a quant, all I care about is – does this person link to this person in any...
Forbes
Jan 13
Comment
If a company holds the same stock in a number of portfolios, should you? If it holds a micro-cap stock in a large-cap fund, should you? I won’t answer that question, but I want to talk about TIAA-CREF and their position in Vanda...
StreetInsider.com
Dec 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharmaceuticals+%28VNDA%29+Announces+Exclusive+License+Agreement+with+Megapharm+for+Commercialization+of+Fanapt+in+Israel/7014552.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
